Publications found:
387
Sort by:
Global Quinine Sulphate Market Growth 2025-2031
US$ 3,660.00
The global Quinine Sulphate market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tari...
October 2025
94 pages
Global Saline Laxative Market Growth 2025-2031
US$ 3,660.00
The global Saline Laxative market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tarif...
October 2025
107 pages
Global Sexual Dysfunction Drugs Market Growth 2025-2031
US$ 3,660.00
The global Sexual Dysfunction Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U...
October 2025
114 pages
Global Short Bowel Syndrome Drugs Market Growth 2025-2031
US$ 3,660.00
The global Short Bowel Syndrome Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
98 pages
Global Sleeping Aids Market Growth 2025-2031
US$ 3,660.00
The global Sleeping Aids market size is predicted to grow from US$ 70520 million in 2025 to US$ 96660 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031. The impact of the lat...
October 2025
125 pages
Global Iron Drugs Market Growth 2025-2031
US$ 3,660.00
The global Iron Drugs market size is predicted to grow from US$ 4645 million in 2025 to US$ 7004 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031. The impact of the latest U...
October 2025
95 pages
Global Topical Pain Relief Gel Market Growth 2025-2031
US$ 3,660.00
The global Topical Pain Relief Gel market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U....
October 2025
121 pages
Global Allergy Medicine Market Growth 2025-2031
US$ 3,660.00
The global Allergy Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tari...
October 2025
102 pages
Global Antigout Drug Market Growth 2025-2031
US$ 3,660.00
The global Antigout Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff...
October 2025
96 pages
Hepatitis Therapeutics Market Size, Share & Trends Analysis Report By Disease (Hepatitis A, Hepatitis B, Hepatitis C), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global hepatitis therapeutics market is expected to reach USD 25.8 billion by 2025 according to a new report by Grand ... disease with subsequently surge in treatment rate HCV, thus hepatitis C therapeutics held the majority market share in 2016 In 2016, North American region accounted for ...
September 2025
150 pages
India Amoxicillin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Suspension), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Respiratory Tract Infections, Skin Infections, UTI, Kidney Infections, Ear & Nose Infections, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
India Amoxicillin Market was valued at USD 214.25 Million in 2024 and is expected to reach USD 257.12 Million by 2030, growing with a CAGR of 3.23% in the forecast period. The India Amoxicillin market...
September 2025
88 pages
India Artesunate Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Injection), By Route of Administration (Oral v/s Intravenous), By Application (Malaria, Parasitic Infections, COVID-19, Others), By Distribution Channel (Online v/s Offline), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
India Artesunate Market was valued at USD 96.54 Million in 2024 and is expected to reach USD 135.91 Million by 2030, growing with a CAGR of 6.01% in the forecast period. The India artesunate market is...
September 2025
88 pages
India Azithromycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Powder, Solution/Drops), By Route of Administration (Oral, Injectable, Ophthalmic), By Distribution Channel (Online v/s Offline), By Application (Middle Ear Infections, Strep Throat, Pneumonia, Travelers Diarrhoea, Sexually Transmitted Infections, Others), By End User (Adult v/s Pediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
India Azithromycin Market was valued at USD 85.81 Million in 2024 and is expected to reach USD 121.76 Million by 2030, growing with a CAGR of 6.11% in the forecast period. The azithromycin market in I...
September 2025
88 pages
India Cefixime Market By Route of Administration (Oral v/s Intravenous), By Dose (100 mg, 200 mg, 500 mg, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Powder, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary tract infections, Otitis media, Pharyngitis and tonsillitis, Others), By End User (Adult v/s Children), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
India Cefixime Market was valued at USD 72.11 Million in 2024 and is expected to reach USD 99.81 Million by 2030, growing with a CAGR of 5.71% in the forecast period. The India cefixime market has wit...
September 2025
70 pages
India Cefoperazone Market By Composition (Single, Combinational), By Route of Administration (Intramuscular v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infections, Respiratory Infections, Skin Infections, Urinary Infections, Others), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
India Cefoperazone Market was valued at USD 198.54 Million in 2024 and is expected to reach USD 271.68 Million by 2030, growing with a CAGR of 5.51% in the forecast period. The India Cefoperazone mark...
September 2025
70 pages
India Ceftriaxone Market By Dose (100 mg, 200 mg, 250 mg, 500 mg and Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Intramuscular Injection, Intravenous Injection, Infusion, Others), By Distribution Channel (Online v/s Offline), By Application (Endocarditis, Meningitis, Pneumonia, Bone and Joint Infections, Intra-Abdominal Infections, Skin Infections, Urinary Tract Infections, Gonorrhoea, Others), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
India Ceftriaxone Market was valued at USD 205.65 Million in 2024 and is expected to reach USD 262.72 Million by 2030, growing with a CAGR of 4.31% in the forecast period. The India Ceftriaxone market...
September 2025
70 pages
India Ciprofloxacin Market By Composition (Single v/s Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear Drop, Injection, Others), By Route of Administration (Oral, Ophthalmic, Otic, Intravenous, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin structure Infections, Bone and Joint infections, Intra-abdominal Infections, Acute Sinusitis, Conjunctivitis, Acute Otitis Externa, Others), By End User (Adult v/s Pediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Ciprofloxacin Market was valued at USD 287.12 Million in 2025 and is expected to reach USD 356.36 Million by 2031, growing with a CAGR of 3.81% in the forecast period. The India Ciprofloxacin ma...
September 2025
70 pages
India Clindamycin HCL Market By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infections, Skin and Soft Tissue Infections, Respiratory Tract Infections, Lung Infections, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Clindamycin HCL Market was valued at USD 156.62 Million in 2025 and is expected to reach USD 184.81 Million by 2031, growing with a CAGR of 2.94% in the forecast period. The India Clindamycin Hy...
September 2025
70 pages
India Clindamycin Phosphate Market By Product Type (Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Gel, Topical Solution, Foam, Injection, Others), By Gender (Men v/s Women), By Distribution Channel (Online v/s Offline), By Application (Acne Vulgaris, Genito-Urinary Infections, Pseudomembranous Colitis, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Clindamycin Phosphate Market was valued at USD 45.64 Million in 2025 and is expected to reach USD 57.67 Million by 2031, growing with a CAGR of 4.12% in the forecast period. The India Clindamyci...
September 2025
70 pages
India Diclofenac Sodium Market By Product Type (Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis, Migraine, Pain and Others), By Route of Administration (Oral, Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Diclofenac Sodium Market was valued at USD 312.43 Million in 2025 and is expected to reach USD 398.41 Million by 2031, growing with a CAGR of 4.27% in the forecast period. The India diclofenac s...
September 2025
88 pages
India Doxycycline Market By Product Type (Doxycycline HCL, Doxycycline Hyclate, Doxycycline Calcium, Doxycycline Monohydrate), By Form (Tablet, Capsule, Injection, Solution, Syrup, Others), By Application (Intestinal Infections, Respiratory Tract Infections, Skin Infections, Genital Infections, Urinary Tract Infections, Others), By Route of Administration (Oral, Intravenous, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Pediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Doxycycline Market was valued at USD 471.45 Million in 2025 and is expected to reach USD 631.17 Million by 2031, growing with a CAGR of 5.12% in the forecast period. The India doxycycline market...
September 2025
70 pages
India Erythromycin Market By Composition (Erythromycin Estolate v/s Erythromycin Stearate), By Application (Respiratory Tract Infections, Eye Infections, Ear Infections, Skin and Soft Tissue Infection, Gastro-intestinal Infections and Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Gel, Tablet, Capsule, Injection, Ointment, Ear and Eye Drops), By Distribution Channel (Online v/s Offline), By Route of Administration (Oral, Topical, Intravenous, Otic and Ophthalmic), By End User (Adult v/s Paediatric), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Erythromycin Market was valued at USD 171.05 Million in 2025 and is expected to reach USD 283.30 Million by 2031, growing with a CAGR of 8.91% in the forecast period. The India erythromycin mark...
September 2025
70 pages
India Gentamycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Eye Drops, Tablet, Capsule, Syrup, Injection, Cream, Gel, Ointment, Others), By Route of Administration (Ophthalmic, Intravenous, Topical, Oral, Others), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infection, Urinary Tract Infection, Sepsis, Meningitis, Skin or Soft Tissue Infection, Upper Respiratory Tract Infection, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F
US$ 3,500.00
India Gentamycin Market was valued at USD 68.32 Million in 2025 and is expected to reach USD 97.87 Million by 2031, growing with a CAGR of 6.31% in the forecast period. The Gentamycin market in India...
September 2025
70 pages
Sleep Aids Market - 2024-2033
US$ 3,400.00
Sleep Aids Market reached US$ 60.96billion in 2023 and is expected to reach US$ 118.97billion by 2033, growing with a CAGR of 7.80% during the forecast period 2026-2033. The Sleep Aids Market emerges...
September 2025
36 pages
Paracetamol Market Size and Forecast (2021 - 2031) , Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Dosage Form (Tablet, Capsule and Others), Indication (Mild and Moderate Pain, Fever and Others), Route Of Administration (Enteral and Parenteral), Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
US$ 4,450.00
The paracetamol market is projected to reach US$15.02 billion by 2031 from US$10.74 billion in 2024. The market is estimated to register a CAGR of 5.0% during 2025-2031. Major factors driving the mark...
September 2025
244 pages
Cough Syrup Market Report by Product Type (Expectorants, Cough Suppressants/Antitussives, Combination Medications), Age Group (Pediatric, Adult), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region 2025-2033
US$ 2,999.00
The global cough syrup market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.65% during 20...
September 2025
141 pages
Non-steroidal Anti-Inflammatory Drugs (NSAID) Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Drug Class (Nonselective NSAIDs and COX-2 Selective NSAIDs), Route Of Administration (Oral, Injectable, and Topical), Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channels), and Geography
US$ 4,450.00
The nonsteroidal anti-inflammatory drugs (NSAID) market size is projected to rise from US$ 24.82 billion in 2024 to US$ 38.38 billion by 2031; the market is expected to register a CAGR of 6.5% during...
August 2025
273 pages
Complementary and Alternative Medicine Market Forecasts to 2032 – Global Analysis By Therapy Type (Whole Medical Systems, Mind-Body Interventions, Biologically Based Practices, Manipulative & Body-Based Methods, Energy Therapies and Other Therapy Types), Form (Tablets & Capsules, Powders, Liquids & Syrups, Ointments & Creams, Teas & Infusions and Other Forms), Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Complementary and Alternative Medicine Market is accounted for $230 billion in 2025 and is expected to reach $1174 billion by 2032 growing at a CAGR of 26.2% d...
August 2025
200 pages
Nicotine Gum Market Report by Type (2 Mg Nicotine Gum, 4 Mg Nicotine Gum, 6 Mg Nicotine Gum), Application (Withdrawal Clinics, Medical Practice, Individual Smokers, and Others), Distribution Channel (Retail Pharmacies, Specialty Stores, Online Stores, and Others), and Region 2025-2033
US$ 2,999.00
The global nicotine gum market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4% during 2025...
August 2025
141 pages
U.S. Antacids Market Size, Share & Trends Analysis Report By Type (Tablet, Liquid, Others), By End-use (Retail Pharmacy, Hospital Pharmacy, Others), Key Companies, Competitive Analysis, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days U.S. Antacids Market The U.S. antacids market size was estimated at USD 3.00 billion in 2024 and is projected to reach USD 3.73 bil...
July 2025
80 pages
Mouth Ulcer Treatment Market Report by Formulation (Gel, Spray, Mouthwash, Lozenges), Drug Class (Corticosteroids, Anesthetics, Analgesics, Antimicrobials, Antihistamines), Indication (Aphthous Stomatitis, Oral Lichen Planus, and Others), and Region 2025-2033
US$ 2,999.00
The global mouth ulcer treatment market size reached USD 1.97 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.55 Billion by 2033, exhibiting a growth rate (CAGR) of 2.7...
June 2025
149 pages
Over the Counter Drugs Market Forecasts to 2032 – Global Analysis By Product (Cough, Cold, and Flu, Products, Analgesics, Dermatological Products, Gastrointestinal Products and Other Products), Dosage Form, Category, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Over the Counter Drugs Market is accounted for $56.61 billion in 2025 and is expected to reach $85.96 billion by 2032 growing at a CAGR of 8% during the foreca...
May 2025
150 pages
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and...
February 2025
587 pages
Paracetamol Market - 2024-2031
US$ 3,400.00
Paracetamol Marketis is growing with a CAGR of 4.30% during the forecast period 2026-2035. The Paracetamol Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned...
December 2024
37 pages
